193 related articles for article (PubMed ID: 4633691)
21. [Liposomal polycarboxylic chelating agents for elimination of toxic metals from the body].
Muzia GI; Kulikov VI
Vestn Akad Med Nauk SSSR; 1990; (8):30-3. PubMed ID: 2125777
[TBL] [Abstract][Full Text] [Related]
22. Validation of a system of models for plutonium decorporation therapy.
Dumit S; Avtandilashvili M; McComish SL; Strom DJ; Tabatadze G; Tolmachev SY
Radiat Environ Biophys; 2019 May; 58(2):227-235. PubMed ID: 30627772
[TBL] [Abstract][Full Text] [Related]
23. A measure of the effectiveness of DTPA chelation therapy in cases of plutonium inhalation and plutonium wounds.
Schofield GB; Lynn JC
Health Phys; 1973 Mar; 24(3):317-26. PubMed ID: 4691640
[No Abstract] [Full Text] [Related]
24. [Efficacy of polymeric 239Pu removal by liposome-encapsulated pentacin].
Smirnov AA; Altukhova GA; Beliaev IK; Ivannikov AT; Il'in LA
Radiobiologiia; 1984; 24(3):386-9. PubMed ID: 6739746
[TBL] [Abstract][Full Text] [Related]
25. A mathematical model for estimation of plutonium in the human body from urine data influenced by DTPA therapy.
Hall RM; Poda GA; Fleming RR; Smith JA
Health Phys; 1978 May; 34(5):419-31. PubMed ID: 711453
[No Abstract] [Full Text] [Related]
26. Removal of polymeric plutonium from dogs with DTPA and glucan.
Rosenthal MW; Lindenbaum A; Baxter DW; Kalesperis GS; Moretti ES; Russell JJ
Radiat Res; 1975 Aug; 63(2):253-61. PubMed ID: 1096228
[No Abstract] [Full Text] [Related]
27. Metabolic and therapeutic studies of plutonium. IV. ANL-7535.
Lindenbaum A; Rosenthal MW; Lund CJ; Russell JJ; Smoler MH; Moretti ES; Brown H
ANL Rep; 1968 Dec; ():60-5. PubMed ID: 5306872
[No Abstract] [Full Text] [Related]
28. Estimation of skeletal plutonium levels based on DPTA-induced radionuclide excretion in feces: possible application to man.
Bhattacharyya MH; Guilmette RA; Peterson DP; Chao FC; Lindinbaum A
Health Phys; 1978 Jun; 34(6):549-55. PubMed ID: 730507
[No Abstract] [Full Text] [Related]
29. [Removal of monomeric 239Pu from bones and liver by liposome-encapsulated pentacin].
Smirnov AA; Beliaev IK; Ivannikov AT; Il'in LA
Biull Eksp Biol Med; 1985 Oct; 100(10):431-3. PubMed ID: 4052611
[TBL] [Abstract][Full Text] [Related]
30. [Metabolism and toxicity of therapeutic chelating agents. 3. Effect of EDTA and DTPA on the excretion of endogenous zinc].
Havlicek F
Strahlentherapie; 1967 Oct; 134(2):296-305. PubMed ID: 4970734
[No Abstract] [Full Text] [Related]
31. Plutonium-DTPA Model Application with USTUR Case 0269.
Konzen K; Brey R; Miller S
Health Phys; 2016 Jan; 110(1):59-65. PubMed ID: 26606066
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of various water-soluble chelator molecules in the liposome-mediated macrophage "suicide" technique.
van Rooijen N; Poppema A
J Pharmacol Toxicol Methods; 1992 Dec; 28(4):217-21. PubMed ID: 1296827
[TBL] [Abstract][Full Text] [Related]
33. Gastrointestinal absorption and retention of plutonium chelates.
Baxter DW; Sullivan MF
Health Phys; 1972 Jun; 22(6):785-6. PubMed ID: 5084011
[No Abstract] [Full Text] [Related]
34. Enhanced decorporation of plutonium by DTPA encapsulated in small PEG-coated liposomes.
Phan G; Le Gall B; Grillon G; Rouit E; Fouillit M; Benech H; Fattal E; Deverre JR
Biochimie; 2006 Nov; 88(11):1843-9. PubMed ID: 16860919
[TBL] [Abstract][Full Text] [Related]
35. Metabolism of plutonium introduced as Tri-N-Butylphosphate complex in the rat and removal attempts by DTPA.
Metivier H; Masse R; Lafuma J
Health Phys; 1983 Jun; 44(6):623-34. PubMed ID: 6853185
[TBL] [Abstract][Full Text] [Related]
36. Effective dose of DTPA, spaced at 3-day intervals, in removal of skeletal plutonium. ANL-7535.
Rosenthal MW; Russell JJ; Moretti ES; Lindenbaum A
ANL Rep; 1968 Dec; ():65-7. PubMed ID: 5306873
[No Abstract] [Full Text] [Related]
37. Pu and Am decorporation in beagles: effects of magnitude of initial Ca-DTPA injection upon chelation efficacy.
Lloyd RD; Jones CW; Taylor GN; Mays CW; Atherton DR
Radiat Res; 1979 Sep; 79(3):630-34. PubMed ID: 113846
[No Abstract] [Full Text] [Related]
38. Computer simulation of metal ion equilibria in biofluids. IV. Plutonium speciation in human blood plasma and chelation therapy using polyaminopolycarboxylic acids.
Duffield JR; May PM; Williams DR
J Inorg Biochem; 1984 Mar; 20(3):199-214. PubMed ID: 6425458
[TBL] [Abstract][Full Text] [Related]
39. Calcium and zinc DTPA administration for internal contamination with plutonium-238 and americium-241.
Kazzi ZN; Heyl A; Ruprecht J
Curr Pharm Biotechnol; 2012 Aug; 13(10):1957-63. PubMed ID: 22352730
[TBL] [Abstract][Full Text] [Related]
40. Decorporation Approach after Rat Lung Contamination with Plutonium: Evaluation of the Key Parameters Influencing the Efficacy of a Protracted Chelation Treatment.
Grémy O; Coudert S; Renault D; Miccoli L
Radiat Res; 2017 Nov; 188(5):552-561. PubMed ID: 28945525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
